Pfizer
Advisory Committee on Immunization Practices Recommends PREVNAR 20® (20-Valent Pneumococcal Conjugate Vaccine) for Adults Aged 50 and Older
24 Oct 2024
Millions of newly eligible U.S. adults aged 50 to 64 now recommended to receive vaccination against invasive pneumococcal disease (IPD) and pneumococcal pneumonia 1 Pfizer Inc. (NYSE: PFE) announced t
U.S. FDA Approves Pfizer’s RSV Vaccine ABRYSVO® for Adults Aged 18 to 59 at Increased Risk for Disease
23 Oct 2024
First and only respiratory syncytial virus (RSV) vaccine indicated for adults younger than 50 Approval based on data from pivotal Phase 3 trial in adults at increased risk of lower respiratory tract d
Pfizer Supplies One Billionth Pneumococcal Conjugated Vaccine Dose for Vaccination of Children in Lower- Income Countries Through Gavi, the Vaccine Alliance
23 Oct 2024
New York, October 22, 2024 – Pfizer today announced it has supplied its 1 billionth pneumococcal conjugate vaccine (PCV) through its collaboration with Gavi, the Vaccine Alliance.
Tim Buckley Elected to Pfizer’s Board of Directors
15 Oct 2024
Pfizer Inc. (NYSE: PFE) today announced the election of Mortimer (“Tim”) J. Buckley to its Board of Directors, effective immediately, following a lengthy and comprehensive search that began in May 202
U.S. FDA Approves Pfizer’s HYMPAVZI™ (marstacimab-hncq) for the Treatment of Adults and Adolescents with Hemophilia A or B Without Inhibitors
12 Oct 2024
HYMPAVZI’s approval is based on Phase 3 study results demonstrating substantial bleed reduction compared to routine prophylaxis and on-demand treatment in eligible patients with hemophilia A or B with
Pfizer’s TALZENNA® in Combination with XTANDI® Prolongs Overall Survival in Phase 3 TALAPRO-2 Trial
10 Oct 2024
First and only PARP inhibitor plus ARPI combination to demonstrate statistically significant overall survival (OS) benefit in patients with metastatic castration-resistant prostate cancer (mCRPC) Resu
Pfizer Declares Fourth-Quarter 2024 Dividend
10 Oct 2024
Board of Directors approves quarterly cash dividend of $0.42 per share Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.42 fourth-quarter 2024 dividend on the company’
Pfizer to Showcase Scientific Advancements in Respiratory and Other Infectious Diseases at IDWeek 2024
09 Oct 2024
Presentations highlight momentum of Pfizer’s portfolio of infectious disease prevention and treatment options Pfizer Inc. (NYSE: PFE) will present data across its infectious disease portfolio at the u
Pfizer Voluntarily Withdraws All Lots of Sickle Cell Disease Treatment OXBRYTA® (voxelotor) From Worldwide Markets
26 Sep 2024
Pfizer Inc. (NYSE: PFE) announced today that it is voluntarily withdrawing all lots of OXBRYTA ® (voxelotor) for the treatment of sickle cell disease (SCD) at this time, in all markets where it is app
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union
23 Sep 2024
Upon authorization by the European Commission (EC), the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and older Data demonstrate that the Omicron KP.2-adapted
Featured
Company story – Quaker Oats
By Kiron Kasbekar | 08 Mar 2024
Quaker Oats is a company whose products I remember from my childhood days. Years before a foreign exchange crisis caused the Indian government to impose curbs on consumer product imports, we used to see a host of foreign brands in the Indian market. Including Quaker Oats, which I remember eating when I was a child, and which has been available for the past two decades or more.
How Quaker Oats grabbed customers’ attention
By Kiron Kasbekar | 07 Mar 2024
Quaker Oats, the American food products giant that was created in 1901 through the merger of many older oat millers, and was acquired by a bigger foods giant, Pepsi, in 2001, has been an innovative company. One example of its innovativeness shows in its packaging – the cereal box it launched in 1915.
Company story – Cunard Line
By Kiron Kasbekar | 12 Jan 2024
The Cunard Line started its life in Glasgow in 1839 as the British and North American Royal Mail Steam-Packet Company when Samuel Cunard was awarded the first British transatlantic steamship mail contract.
Samuel Slater – textile tycoon or traitor?
By Kiron Kasbekar | 26 Dec 2023
Samuel Slater is a name that holds significant importance in the annals of American industrial history. Often referred to as the ‘Father of the American Factory System’, Slater's contributions played a pivotal role in shaping the nation’s industrial landscape.
Underwood Typewriter Company – an icon of the past
By Kiron Kasbekar | 21 Dec 2023
You’ve probably never heard of Underwood typewriters. For the company folded up in 1963 – 60 years ago. You may not even have seen and handled a typewriter, unless someone in your family owned one.
The rise and fall of Chrysler
By Kiron Kasbekar | 16 Dec 2023
A century ago, the American automobile industry was more crowded than a vegetable market on a Sunday morning, with such a wide variety of stuff on sale that buyers were spoilt for choice. Buyers could pick and choose, bargain, pay up and drive out with the newly purchased vehicle.
TRW – the tide turned
By Kiron Kasbekar | 13 Dec 2023
There used to be an American company called Thompson Ramo Wooldridge Inc. This company, which was a global supplier of automotive systems, modules, and components to car and truck manufacturers, started small, as most companies do. Then, as the automotive industry grew bigger, so did TRW.
The rise and fall of Nokia
By Aniket Gupta | 07 Dec 2023
My interest is stories about dominant companies that failed all of a sudden. These companies were once etched into people’s minds but have since become a symbol of nostalgia. One such company, which was the biggest in its industry before it failed catastrophically, is Nokia.
Yahoo!: The first king of the internet
By Aniket Gupta | 01 Dec 2023
The year is 1994. You go to the internet to search for a particular website, but there is no Google that could be used to search your desired website. What do you do? The answer is that you use Yahoo.
.jpg)
